Literature DB >> 23241380

Michael A. Pfaller, M.D.

Stephen A Moser1.   

Abstract

Mesh:

Year:  2012        PMID: 23241380      PMCID: PMC3553891          DOI: 10.1128/JCM.03125-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  21 in total

1.  Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.

Authors:  M A Pfaller; M Castanheira; S R Lockhart; A M Ahlquist; S A Messer; R N Jones
Journal:  J Clin Microbiol       Date:  2012-01-25       Impact factor: 5.948

Review 2.  Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

Authors:  Michael A Pfaller; David Andes; Maiken C Arendrup; Daniel J Diekema; Ana Espinel-Ingroff; Barbara D Alexander; Steven D Brown; Vishnu Chaturvedi; Cynthia L Fowler; Mahmoud A Ghannoum; Elizabeth M Johnson; Cynthia C Knapp; Mary R Motyl; Luis Ostrosky-Zeichner; Thomas J Walsh
Journal:  Diagn Microbiol Infect Dis       Date:  2011-05-04       Impact factor: 2.803

Review 3.  Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Authors:  M A Pfaller; D J Diekema; D Andes; M C Arendrup; S D Brown; S R Lockhart; M Motyl; D S Perlin
Journal:  Drug Resist Updat       Date:  2011-02-24       Impact factor: 18.500

Review 4.  Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Authors:  M A Pfaller; D Andes; D J Diekema; A Espinel-Ingroff; D Sheehan
Journal:  Drug Resist Updat       Date:  2010-11-02       Impact factor: 18.500

5.  In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.

Authors:  J B Pfaller; S A Messer; R J Hollis; D J Diekema; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs.

Authors:  M A Pfaller; S A Messer; K Mills; A Bolmström
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; D Ellis; V Tullio; A Rodloff; W Fu; T A Ling
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

8.  Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.

Authors:  M A Pfaller; S A Messer; L Boyken; C Rice; S Tendolkar; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

9.  Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

Authors:  M A Pfaller; S A Messer; R J Hollis; L Boyken; S Tendolkar; J Kroeger; D J Diekema
Journal:  J Clin Microbiol       Date:  2009-08-05       Impact factor: 5.948

10.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  2 in total

1.  Biographical Feature: Fred C. Tenover, Ph.D., D(ABMM), F(AAM), FIDSA.

Authors:  Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

2.  Biographical Feature: Franklin P. Koontz, Ph.D., D(ABMM), F(AAM).

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.